Urology Times spoke with Raoul S. Concepcion, MD, FACS, and Christopher M. Pieczonka, MD, about advances made in the prostate cancer space in 2020.
EP. 1: PSMA in Prostate Cancer
EP. 2: Metastatic Castrate-Resistant Prostate Cancer
EP. 3: PARP Inhibitors and Immunotherapy in Prostate Cancer
Phase 2 trial launches of combination immunotherapy for mCRPC
Study findings highlight gender gaps in oncology authorship and citation
ORIC-944 shows promise in combination with AR inhibitors in mCRPC
ASCO 2025: What to watch for in GU oncology